Li–Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant

Studies have demonstrated that up to 17% of patients with pancreatic neuroendocrine tumours (pNETs) present pathogenic germline variants (PGVs) in several different genes, irrespective of family cancer history. Li–Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition syndrome relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Riechelmann, Rachel P, Soares, Diogo C, Dias, Carla, Carraro, Dirce M, Torrezan, Giovana T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934963/
https://www.ncbi.nlm.nih.gov/pubmed/36819813
http://dx.doi.org/10.3332/ecancer.2022.1487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934963/
https://www.ncbi.nlm.nih.gov/pubmed/36819813
http://dx.doi.org/10.3332/ecancer.2022.1487

Ejemplares similares